NYC Cancer Outreach Network for Breast, Cervical, and Colorectal Cancer Screening

This study, called NYC CONNECT, is looking at ways to help people get screened for breast, cervical, and colorectal cancer. It compares two approaches: one uses educational materials and community health workers (CHWs) to help you navigate to screening and social services (Patient Navigation - More Intensive), and the other uses educational materials and CHWs to help with social services only (Patient Navigation - Less Intensive). The goal is to see which approach is better at increasing cancer screening rates. You might be able to join if you are between 21 and 75 years old and are due for a mammogram, Pap smear, HPV test, or colorectal cancer screening. The study will measure how many participants receive at least one cancer screening within 6 months of joining.

Study design
This is a randomized controlled trial comparing two different approaches to increasing cancer screening rates. It plans to enroll 2160 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for up to 6 months after enrolling to see if they receive a cancer screening.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05742178

NYC Cancer Outreach Network in Neighborhoods for Equity and Community Translation

Recruiting
NAAges 21–75InterventionalScreening
NYU Langone Health
~2,160 participants
Updated 2025-12-18 on ClinicalTrials.gov
What's tested:Patient Navigation (PN) - More IntensiveEducational MaterialsPatient Navigation (PN) - Less Intensive

At a glance

Recruiting sites
2 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Percentage of Participants who Receive at Least 1 Cancer Screening at 6 Months After Study Enrollment
Measured over Up to Month 6
Cancer Screening
2 sites across 1 states
New York2
  • Chau Trinh, PhD · PRINCIPAL_INVESTIGATOR · NYU Langone Health

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Women between the ages of 21 and 75 years;
Men between the ages of 45 and 75 years;
Women (40-74 years) who have not had a mammogram in the past 12 months, a Pap smear in the last 3 years (21-64 years old) or HPV test in the last 5 years (30-64 years old), or women 45-75 years old who are not up-to-date on colorectal cancer screening (Fecal occult blood test (FOBT)/Fecal immunochemical test (FIT) past year, computerized tomography (CT) colonography or sigmoidoscopy past 5 years, or colonoscopy past 10 years);
Men not up-to-date on colorectal cancer screening (FOBT/FIT past year, computerized tomography (CT) colonography or sigmoidoscopy past 5 years, or colonoscopy past 10 years);
Must speak either English, Spanish, Haitian-Creole, French, or Chinese (Mandarin and Cantonese);
Lives in East Flatbush (zip codes: 11236, 11203, 11212, 11226); Sunset Park (zip codes: 11215, 11220, 11232); Highbridge (zip code 10452, 10455, 10451); or Morrisania (zip codes: 10456, 10459)

Exclusion

Previous or current diagnosis of any cancer;
Pregnancy (breast and cervical cancer only);
Current participation in an existing cancer navigation program;
Currently in hospice care;
At least 66 years of age with advanced illness or frailty or who live in long-term institution for more than 90 days;
Bilateral mastectomy or right and left unilateral mastectomy (breast cancer only);
Hysterectomy with no residual cervix (cervical cancer only);
Total colectomy (colorectal cancer only).
  • Percentage of Participants who Receive at Least 1 Cancer Screening at 6 Months After Study EnrollmentUp to Month 6

    Cancer screening defined as a breast, cervical, or colorectal cancer screening.